Literature DB >> 35440725

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.

Bob T Li1, Bobby Daly2, Mary Gospodarowicz3, Monica M Bertagnolli4, Otis W Brawley5, Bruce A Chabner6,7, Lola Fashoyin-Aje8, R Angelo de Claro8, Elizabeth Franklin9, Jennifer Mills10, Jeff Legos11, Karen Kaucic12, Mark Li13, Lydia The14, Tina Hou14, Ting-Hui Wu14, Bjorn Albrecht14, Yi Shao14, Justin Finnegan15, Jing Qian16, Javad Shahidi17, Eduard Gasal18, Craig Tendler19, Geoffrey Kim20, James Yan21, Phuong Khanh Morrow22, Charles S Fuchs23,24, Lianshan Zhang25, Robert LaCaze26, Stefan Oelrich26, Martin J Murphy7,27,28, Richard Pazdur8, Kevin Rudd16, Yi-Long Wu29.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35440725     DOI: 10.1038/s41591-022-01775-6

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  24 in total

1.  Conceptual Model for Accrual to Cancer Clinical Trials.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; Ann M Geiger; David E Gerber; John V Cox; Rasmi Nair; Celette Sugg Skinner
Journal:  J Clin Oncol       Date:  2019-06-05       Impact factor: 44.544

2.  Advantages of a Truly Open-Access Data-Sharing Model.

Authors:  Monica M Bertagnolli; Oliver Sartor; Bruce A Chabner; Mace L Rothenberg; Sean Khozin; Charles Hugh-Jones; David M Reese; Martin J Murphy
Journal:  N Engl J Med       Date:  2017-03-23       Impact factor: 91.245

3.  Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives.

Authors:  Jeffrey A Switzer; Bart M Demaerschalk; Jipan Xie; Liangyi Fan; Kathleen F Villa; Eric Q Wu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-12-04

4.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

5.  OncoKB: A Precision Oncology Knowledge Base.

Authors:  Debyani Chakravarty; Jianjiong Gao; Sarah M Phillips; Ritika Kundra; Hongxin Zhang; Jiaojiao Wang; Julia E Rudolph; Rona Yaeger; Tara Soumerai; Moriah H Nissan; Matthew T Chang; Sarat Chandarlapaty; Tiffany A Traina; Paul K Paik; Alan L Ho; Feras M Hantash; Andrew Grupe; Shrujal S Baxi; Margaret K Callahan; Alexandra Snyder; Ping Chi; Daniel Danila; Mrinal Gounder; James J Harding; Matthew D Hellmann; Gopa Iyer; Yelena Janjigian; Thomas Kaley; Douglas A Levine; Maeve Lowery; Antonio Omuro; Michael A Postow; Dana Rathkopf; Alexander N Shoushtari; Neerav Shukla; Martin Voss; Ederlinda Paraiso; Ahmet Zehir; Michael F Berger; Barry S Taylor; Leonard B Saltz; Gregory J Riely; Marc Ladanyi; David M Hyman; José Baselga; Paul Sabbatini; David B Solit; Nikolaus Schultz
Journal:  JCO Precis Oncol       Date:  2017-05-16

6.  Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical Trials.

Authors:  Kenneth A Getz
Journal:  Clin Ther       Date:  2017-10-25       Impact factor: 3.393

7.  Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.

Authors:  David G Pfister; David M Rubin; Elena B Elkin; Ushma S Neill; Elaine Duck; Mark Radzyner; Peter B Bach
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

8.  Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:  Ahmet Zehir; Ryma Benayed; Ronak H Shah; Aijazuddin Syed; Sumit Middha; Hyunjae R Kim; Preethi Srinivasan; Jianjiong Gao; Debyani Chakravarty; Sean M Devlin; Matthew D Hellmann; David A Barron; Alison M Schram; Meera Hameed; Snjezana Dogan; Dara S Ross; Jaclyn F Hechtman; Deborah F DeLair; JinJuan Yao; Diana L Mandelker; Donavan T Cheng; Raghu Chandramohan; Abhinita S Mohanty; Ryan N Ptashkin; Gowtham Jayakumaran; Meera Prasad; Mustafa H Syed; Anoop Balakrishnan Rema; Zhen Y Liu; Khedoudja Nafa; Laetitia Borsu; Justyna Sadowska; Jacklyn Casanova; Ruben Bacares; Iwona J Kiecka; Anna Razumova; Julie B Son; Lisa Stewart; Tessara Baldi; Kerry A Mullaney; Hikmat Al-Ahmadie; Efsevia Vakiani; Adam A Abeshouse; Alexander V Penson; Philip Jonsson; Niedzica Camacho; Matthew T Chang; Helen H Won; Benjamin E Gross; Ritika Kundra; Zachary J Heins; Hsiao-Wei Chen; Sarah Phillips; Hongxin Zhang; Jiaojiao Wang; Angelica Ochoa; Jonathan Wills; Michael Eubank; Stacy B Thomas; Stuart M Gardos; Dalicia N Reales; Jesse Galle; Robert Durany; Roy Cambria; Wassim Abida; Andrea Cercek; Darren R Feldman; Mrinal M Gounder; A Ari Hakimi; James J Harding; Gopa Iyer; Yelena Y Janjigian; Emmet J Jordan; Ciara M Kelly; Maeve A Lowery; Luc G T Morris; Antonio M Omuro; Nitya Raj; Pedram Razavi; Alexander N Shoushtari; Neerav Shukla; Tara E Soumerai; Anna M Varghese; Rona Yaeger; Jonathan Coleman; Bernard Bochner; Gregory J Riely; Leonard B Saltz; Howard I Scher; Paul J Sabbatini; Mark E Robson; David S Klimstra; Barry S Taylor; Jose Baselga; Nikolaus Schultz; David M Hyman; Maria E Arcila; David B Solit; Marc Ladanyi; Michael F Berger
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

9.  Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Authors:  Joseph M Unger; Riha Vaidya; Dawn L Hershman; Lori M Minasian; Mark E Fleury
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

10.  Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective.

Authors:  Keith T Flaherty; James H Doroshow; Susan Galbraith; Antoni Ribas; Paul G Kluetz; Richard Pazdur; Marc R Theoret
Journal:  Cancer Discov       Date:  2021-07-21       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.